Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Ultra High-Mass Spectrometer

By Drug Discovery Trends Editor | May 25, 2010

Shimadzu Scientific Instruments has partnered with CovalX to offer the AXIMA MegaTOF, an integrated MALDI solution for ultra high-mass applications, including protein complex characterization, therapeutic protein aggregates, antibody-antigen interactions, polymer analysis and high mass bioimaging.

The high-sensitivity MegaTOF, which combines a high-performance Shimadzu linear MALDI TOF mass spectrometer with a CovalX high-mass detection system, detects macromolecules up to 1,500 kDa. When analyzing intact protein complexes by high-mass MALDI TOF, it is crucial to stabilize the complexes with highly efficient cross-linking reagents. The MegaTOF achieves this with the combination of CovalX’s high-mass system offering nM detection of macromolecules up to 1,500 kDa and MALDI stabilization kits, which provide special cross-linking reagents and buffers for fast and specific stabilization of protein interactions.

These reagents contain “cocktails” of cross-linkers with different spacer lengths that can covalently bind specific proteins with a high degree of efficiency, even in contaminated and unpurified samples. Additionally, the MegaTOF can detect protein interactions such as aggregation directly from formulation mixtures, which is important for characterizing biopharmaceuticals.

MegaTOF is also equipped with a conventional detector for low mass samples (< 20 kDa). In addition, existing Shimadzu AXIMA MALDI systems (Assurance, Confidence and Performance) can be retrofitted with CovalX’s HM2 or HM2 TUVO high-mass system.

Shimadzu Scientific Instruments Inc. 


Filed Under: Drug Discovery

 

Related Articles Read More >

S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
Drug companies sign “Most Favored Nation” deals, then raise prices anyway
New gonorrhea antibiotic could treat resistant infections
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE